TCR2 Therapeutics Inc.
TCRR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $33 | $223 | $94 | $65 |
| Short-Term Investments | $116 | $43 | $134 | $93 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $11 | $8 | $5 |
| Total Curr. Assets | $178 | $276 | $236 | $163 |
| Property Plant & Equip (Net) | $29 | $45 | $10 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $1 | $0 |
| Total NC Assets | $31 | $47 | $11 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $208 | $323 | $246 | $169 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $2 | $2 |
| Short-Term Debt | $50 | $3 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $12 | $0 | $0 |
| Other Curr. Liab. | $11 | $1 | $6 | $5 |
| Total Curr. Liab. | $64 | $19 | $9 | $8 |
| LT Debt | $3 | $23 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $1 |
| Total NC Liab. | $3 | $23 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $67 | $42 | $10 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $169 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$501 | -$350 | -$250 | -$183 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $643 | $631 | $486 | $174 |
| Total Equity | $141 | $281 | $237 | $160 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $208 | $323 | $246 | $169 |
| Net Debt | $21 | -$196 | -$94 | -$65 |